Elevaris Medical Devices Unites Spectra and XLPT under One Brand

• Spectra Medical and XL Precision Technologies have officially rebranded as Elevaris Medical Devices, reflecting the merger of their strengths in medical device development and manufacturing.

• The rebranding follows a September 2024 acquisition by QHP Capital, combining capabilities in precision manufacturing and customer service for medical device OEMs.

Elevaris Medical Devices was established following the integration of Spectra Medical and XL Precision Technologies, two well-regarded Contract Development and Manufacturing Organisations (CDMOs) within the medical device sector. The merger, announced in September 2024, combines the complementary strengths of both companies in precision manufacturing and technical customer support for Original Equipment Manufacturers (OEMs), ranging from large-scale enterprises to startups.

The newly unified brand seeks to honour the legacy of each company while positioning itself to offer unparalleled customer solutions. Elevaris Medical Devices aims to enhance the development of next-generation medical devices by leveraging deep industry knowledge, technical expertise, and a collaborative approach to product design and manufacturing.

Richard Zrebiec, CEO of Elevaris Medical Devices, highlighted the strategic importance of the rebrand, saying, “The acquisition late last year brought together two long-trusted companies with highly complementary capabilities. Today, as we complete integration, we believe operating under one brand demonstrates our combined commitment to our customers’ success.”

The brand’s new identity reflects the company’s aim to be the preferred partner for medical device companies, offering a comprehensive suite of services from concept development to manufacturing. Through its unified approach, Elevaris Medical Devices is positioned to support the medical device industry in advancing global healthcare through precision manufacturing.